Business Description
OncoCyte Corp
NAICS : 541380
SIC : 8734
ISIN : US68235C1071
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.67 | |||||
Equity-to-Asset | 0.16 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -7.35 | |||||
Beneish M-Score | -4.05 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.2 | |||||
3-Year EBITDA Growth Rate | 31.3 | |||||
3-Year EPS without NRI Growth Rate | 34 | |||||
3-Year FCF Growth Rate | 28.1 | |||||
3-Year Book Growth Rate | -36.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 22.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 101.65 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 41.91 | |||||
12-1 Month Momentum % | -60.41 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.78 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.67 | |||||
Days Sales Outstanding | 324.54 | |||||
Days Payable | 357 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.7 | |||||
Shareholder Yield % | -32.49 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.07 | |||||
Operating Margin % | -1590.38 | |||||
Net Margin % | -2890.23 | |||||
FCF Margin % | -1361.85 | |||||
ROE % | -132.13 | |||||
ROA % | -50.21 | |||||
ROIC % | -31.21 | |||||
ROC (Joel Greenblatt) % | -415.71 | |||||
ROCE % | -38.77 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 18.04 | |||||
PB Ratio | 2.16 | |||||
EV-to-EBIT | -1.38 | |||||
EV-to-EBITDA | -1.46 | |||||
EV-to-Revenue | 27.68 | |||||
EV-to-Forward-Revenue | 10.19 | |||||
EV-to-FCF | -2.03 | |||||
Earnings Yield (Greenblatt) % | -72.46 | |||||
FCF Yield % | -46.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
OncoCyte Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.279 | ||
EPS (TTM) (€) | -1.747 | ||
Beta | 0 | ||
Volatility % | 34.71 | ||
14-Day RSI | 41.91 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 3.12 | ||
12-1 Month Momentum % | -60.41 | ||
52-Week Range (€) | 2.76 - 7.88 | ||
Shares Outstanding (Mil) | 8.26 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
OncoCyte Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
OncoCyte Corp Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
OncoCyte Corp Frequently Asked Questions
What is OncoCyte Corp(FRA:7OC0)'s stock price today?
When is next earnings date of OncoCyte Corp(FRA:7OC0)?
Does OncoCyte Corp(FRA:7OC0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |